Differentiation syndrome in patients with acute promyelocytic leukemia
- PMID: 36721680
- PMCID: PMC9880381
- DOI: 10.1002/ccr3.6697
Differentiation syndrome in patients with acute promyelocytic leukemia
Abstract
A 48-year-old male diagnosed with acute promyelocytic leukemia (APL) started on all-trans-retinoic acid and arsenic trioxide, developed typical symptoms of differentiation syndrome, and improved dramatically on steroids. Hence, any APL patient started on chemotherapy, needs to be monitored closely for developing differentiation syndrome and to start steroid upon suspicion.
Keywords: ATRA syndrome; acute leukemia; steroids.
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that there was conflict no of interest regarding the publication of this case report.
Figures
References
-
- Ibrahim FA, Yassin MA, El Ayoubi HR, et al. Clinico‐pathological profile of acute promyelocytic leukaemia at Al‐Amal oncology‐Haematology Centre, Qatar. East Mediterr Health J. 2010;16(9):958‐965. - PubMed
-
- Stahl M, Tallman MS. Differentiation syndrome in acute promyelocytic leukaemia. Br J Haematol. 2019;187(2):157‐162. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
